Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-31 @ 5:55 AM
Study NCT ID:
NCT00765856
Status:
TERMINATED
Last Update Posted:
2020-12-16
First Post:
2008-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Sponsor:
Endo Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2010-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-02
First Submit QC Date:
None
Study First Post Date:
2008-10-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-14
Results First Submit QC Date:
None
Results First Post Date:
2020-12-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-20
Last Update Post Date:
2020-12-16
Last Update Post Date Type:
ACTUAL